John M Rossi Selected Research

brexucabtagene autoleucel

1/2021	KTE-X19 anti-CD19 CAR T-cell therapy in adult relapsed/refractory acute lymphoblastic leukemia: ZUMA-3 phase 1 results.
10/2020	Management of a patient with mantle cell lymphoma who developed severe neurotoxicity after chimeric antigen receptor T-cell therapy in ZUMA-2.
1/2020	KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John M Rossi Research Topics

Disease

6	B-Cell Lymphoma (Lymphoma, B Cell) 11/2021 - 01/2019
5	Neoplasms (Cancer) 01/2021 - 01/2015
3	Lymphoma (Lymphomas) 01/2022 - 01/2017
3	Cytokine Release Syndrome 11/2021 - 01/2017
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2022 - 01/2019
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 10/2020 - 01/2020
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2020 - 01/2019
2	Disease Progression 01/2020 - 01/2015
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021
1	Multiple Myeloma 01/2021
1	Inflammation (Inflammations) 10/2020
1	Brain Edema (Cerebral Edema) 10/2020
1	Body Weight (Weight, Body) 01/2020
1	Leukemia 01/2019

Drug/Important Bio-Agent (IBA)

8	axicabtagene ciloleucelIBA 01/2022 - 01/2017
7	Chimeric Antigen ReceptorsIBA 01/2022 - 01/2020
3	brexucabtagene autoleucelIBA 01/2021 - 01/2020
2	Monoclonal AntibodiesIBA 01/2022 - 01/2019
2	tocilizumab (atlizumab)FDA Link 11/2021 - 01/2021
2	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2021 - 01/2021
1	Alkylating AgentsIBA 01/2022
1	fludarabineIBA 01/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2021
1	AntigensIBA 01/2021
1	Antigen Receptors (Antigen Receptor)IBA 01/2021
1	thymoglobulin FDA Link 10/2020
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2020
1	AnthracyclinesIBA 01/2019
1	HematinicsIBA 01/2015
1	Erythropoietin FDA Link 01/2015
1	Epidermal Growth Factor (EGF)IBA 01/2015
1	Proteins (Proteins, Gene)FDA Link 01/2015
1	Cell Surface ReceptorsIBA 01/2015
1	Erythropoietin Receptors (Erythropoietin Receptor)IBA 01/2015
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2015

Therapy/Procedure

6	Therapeutics 01/2022 - 01/2019
3	Drug Therapy (Chemotherapy) 01/2022 - 01/2019
1	Immunotherapy 01/2021
1	Stem Cell Transplantation 01/2019